Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.090
-0.120 (-9.92%)
At close: Feb 12, 2026, 4:00 PM EST
1.080
-0.010 (-0.92%)
After-hours: Feb 12, 2026, 7:55 PM EST
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $914.28 thousand as of February 12, 2026. Its market cap has decreased by -67.82% in one year.
Market Cap
914.28K
Enterprise Value
-3.92M
1-Year Change
-67.82%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since October 28, 2016, Biodexa Pharmaceuticals's market cap has decreased from $55.80M to $914.28K, a decrease of -98.36%. That is a compound annual growth rate of -35.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 914.28K | -51.98% |
| Dec 31, 2025 | 1.90M | -19.06% |
| Dec 31, 2024 | 2.35M | -66.49% |
| Dec 29, 2023 | 7.02M | 64.98% |
| Dec 30, 2022 | 4.26M | -67.32% |
| Dec 31, 2021 | 13.02M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bone Biologics | 2.55M |
| Cardio Diagnostics Holdings | 2.45M |
| Ernexa Therapeutics | 2.42M |
| Ensysce Biosciences | 2.21M |
| Azitra | 2.16M |
| CDT Equity | 2.14M |
| PMGC Holdings | 1.99M |
| Clearmind Medicine | 1.86M |